Search

Coherus Oncology Inc

Suletud

SektorTervishoid

1.61 -3.01

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.6

Max

1.67

Põhinäitajad

By Trading Economics

Sissetulek

-279M

-38M

Müük

-438K

12M

P/E

Sektori keskmine

3.509

60.549

Aktsiakasum

-0.25

Kasumimarginaal

-308.197

Töötajad

145

EBITDA

9.3M

-34M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+400% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

6. aug 2026

Turustatistika

By TradingEconomics

Turukapital

-19M

241M

Eelmine avamishind

4.62

Eelmine sulgemishind

1.61

Uudiste sentiment

By Acuity

50%

50%

160 / 342 Pingereas Healthcare

Coherus Oncology Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

8. juuli 2026, 23:51 UTC

News

Broadcom shares rise in after-market hours as analysts project $172 billion in revenue next year, driven by AI infrastructure spending.

8. juuli 2026, 23:51 UTC

News
Social Media

Costco Wholesale reported net sales of $29.24 billion for June but shares declined in after-hours trading amid mixed investor sentiment and broader market trends.

8. juuli 2026, 23:46 UTC

News
ETF Constituents
Macro News
Correlated Moves

The Financial Select Sector SPDR Fund is higher in after-market trading, supported by strong seasonal patterns and movements in major bank holdings.

8. juuli 2026, 23:41 UTC

News
Social Media
Correlated Moves

Advanced Micro Devices shares are declining in after-hours trading amid negative sentiment in semiconductor stocks, following the announcement of its upcoming earnings report.

8. juuli 2026, 23:41 UTC

Social Media
News

NVIDIA Corp shares declined in after-market trading amid concerns over AI spending and competition. Analysts note cautious investor sentiment contributing to the bearish outlook.

8. juuli 2026, 23:41 UTC

News
Social Media
Correlated Moves

Micron Technology shares traded higher after notable options activity, with $7.2 million in orders for $815 7/17 Puts contributing to a total premium of over $21.5 million.

8. juuli 2026, 23:36 UTC

News

PayPal Holdings Inc. shares fell in after-market trading amid geopolitical tensions and investor risk aversion following President Trump's announcement on the Iran ceasefire.

8. juuli 2026, 23:26 UTC

News

Lam Research Corporation will hold a financial conference call on July 29, 2026, to discuss June quarter results. Shares are higher in after-market trading.

8. juuli 2026, 23:11 UTC

Correlated Moves
Macro News
ETF Constituents
News

The Consumer Discretionary Select Sector SPDR Fund is higher in after-market trading, bolstered by Levi Strauss & Co.'s strong Q2 results and summer performance trends.

8. juuli 2026, 23:06 UTC

News

United Airlines shares traded lower in after-market hours following a judge's ruling to allow a class-action lawsuit over misleading "window seat" charges.

8. juuli 2026, 23:06 UTC

News

Monster Beverage Corp announced a 2-for-1 stock split, effective August 10, 2026. Shares are trading higher in after-market hours following the news.

8. juuli 2026, 23:06 UTC

Correlated Moves
News
Social Media
ETF Constituents

SPDR Dow Jones Industrial Average ETF Trust is lower in after-market hours, reflecting declines in key contributors amid rising inflation concerns from escalating Middle East tensions.

8. juuli 2026, 23:01 UTC

News

Geopolitical tensions following U.S. strikes in Iran have boosted United States Oil Fund LP in after-market trading, reflecting strong upward momentum since Wednesday's close.

8. juuli 2026, 20:13 UTC

ETF Constituents
Correlated Moves
News

The Vanguard Large-Cap ETF is lower in after-hours trading, reflecting broader market declines amid rising crude oil prices and escalating tensions in the Middle East.

8. juuli 2026, 20:07 UTC

News
Correlated Moves

Bitcoin is trading lower amid heightened geopolitical tensions and rising inflation concerns. Earlier in the session, Bitcoin briefly declined significantly before recovering slightly.

8. juuli 2026, 20:07 UTC

News
Correlated Moves

Geopolitical tensions following President Trump's U.S.-Iran ceasefire announcement support a modest rise in CAD/HKD during Wednesday's session. The pair is up since Tuesday's close.

8. juuli 2026, 20:07 UTC

News
Correlated Moves

Bitcoin is trading lower amid heightened geopolitical tensions following President Trump's declaration on Iran. The asset remains under pressure from rising inflation concerns.

8. juuli 2026, 20:06 UTC

Social Media
Macro Event
News

Cisco Systems Inc shares are higher today following the US Wholesale Inventories report, which showed a smaller-than-expected increase for May. Concerns about a price breakdown persist.

8. juuli 2026, 20:04 UTC

News

J B Hunt Transport shares rise as Stephens initiates Overweight rating and TD Cowen raises price target to $265 ahead of earnings report.

8. juuli 2026, 20:04 UTC

Correlated Moves
Social Media
News

Intuit Inc. shares are lower amid an investigation into potential securities fraud by Bleichmar Fonti & Auld LLP related to pricing issues ahead of tax season.

8. juuli 2026, 20:04 UTC

Social Media
News
Correlated Moves

Amazon shares are lower as TD Cowen lowers its price target to $340 ahead of earnings, amid concerns over significant investments and high borrowing.

8. juuli 2026, 20:04 UTC

News
Social Media
Correlated Moves

Alphabet Inc shares are lower despite confirmation of a major presence at the Calgary Stampede, reflecting broader market trends amid global tensions.

8. juuli 2026, 20:04 UTC

News
Correlated Moves

Alphabet Inc shares are lower, affected by declines in the Interactive Media & Services sub-sector and a drop in the S&P 500 Index.

8. juuli 2026, 20:04 UTC

Social Media
News
Correlated Moves

Meta Platforms Inc. shares are lower as France's competition authority mandates renewed negotiations with local media over unpaid publishing fees, amid broader market declines.

8. juuli 2026, 20:04 UTC

Social Media
News
Correlated Moves

Qualcomm Inc is rising amid strong gains in the Semiconductors sector. Social media discussions note key resistance levels around $185.13 and $186.32.

8. juuli 2026, 20:03 UTC

ETF Constituents
News
Correlated Moves

Vanguard Small-Cap ETF is lower as Goldman Sachs warns of waning favorable conditions for small-cap stocks amid rising interest burdens and declining holdings.

8. juuli 2026, 20:03 UTC

Macro News
News
ETF Constituents
Correlated Moves

The Industrial Select Sector SPDR Fund is trading lower as rising oil prices and inflation concerns pressure the sector amid geopolitical tensions.

8. juuli 2026, 20:02 UTC

News

Expedia Group Inc shares declined as geopolitical tensions rose after President Trump's Iran ceasefire remarks, raising concerns about travel demand and costs.

8. juuli 2026, 20:02 UTC

News

NXP Semiconductors NV is trading higher, supported by Cantor Fitzgerald's endorsement and positive outlook for its automotive segment growth through 2027.

8. juuli 2026, 19:57 UTC

Social Media
News

Tesla Inc. shares are lower today amid operational pressures and competitive developments, including scrutiny over Full Self-Driving and new competition in robotics.

Võrdlus sarnastega

Hinnamuutus

Coherus Oncology Inc Prognoos

Hinnasiht

By TipRanks

400% tõus

12 kuu keskmine prognoos

Keskmine 8.25 USD  400%

Kõrge 12 USD

Madal 4 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Coherus Oncology Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

5 ratings

5

Osta

0

Hoia

0

Müü

Sentiment

By Acuity

160 / 342 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Coherus Oncology Inc

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of cancer treatments primarily in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel PD-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype G1 (IgG1) monoclonal antibody targeting interleukin 27. It is also developing CHS-114, an investigational highly specific human afucosylated IgG1 monoclonal antibody selectively targeting CCR8, a chemokine receptor highly expressed on Treg cells in the tumor microenvironment (TME); and CHS-1000, an antibody targeting human ILT4 designed to improve anti-PD-1 clinical benefit by transforming an unfavorable TME to a more favorable TME. In addition, the company's licensed immuno-oncology programs include NZV930, an antibody designed to inhibit cluster of differentiation 73; and GSK4381562, an antibody targeting CD112R for the treatment of solid tumors. Further, it offers YUSIMRY, a biosimilar to Humira for the treatment of patients with inflammatory diseases characterized by increased production of tumor necrosis factor (TNF) in the body, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, psoriasis, and ulcerative colitis. It collaboration agreement with Junshi Biosciences for the co-development and commercialization of toripalimab; agreement with Surface and Adimab LLC; license agreements with Bioeq AG and Genentech, Inc., as well as Vaccinex, Inc.; and out-licensing agreement with Novartis Institutes for Biomedical Research, Inc. and GlaxoSmithKline Intellectual Property No. 4 Limited. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.
help-icon Live chat